Two optimal prefilter cutoff frequencies needed for SPECT images of myocadial perfusion in a one-day protocol

Journal of Nuclear Medicine Technology

Volumn 25, Issue 4, 1997, Pages 256-260

  Ohnishi, Hideo ^a   Ota, Toyotsugu ^a   Takada, Masahiko ^a   Kida, Tetsuo ^a   Noma, Kazuo ^a   Matsuo, Satoru ^a   Masuda, Kazutaka ^a   Yamamoto, Itsuo ^a   Monta, Rikushi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cutoff frequency; Myocardial perfusion imaging; Normalized mean square error; SPECT

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M;

ARTICLE; CLINICAL PROTOCOL; FILTER; HEART MUSCLE PERFUSION; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; NORMAL HUMAN; PHANTOM; RADIATION DOSE; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MODELS, CARDIOVASCULAR; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031437843     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Strauss HW, Boucher CA. Myocardial perfusion studies: lessons from a decade of clinical use. Radiology 1986;160:577-584.
2. Maddahi J, Kiat H, Van Train KF, et al. Myocardial perfusion imaging with technetium-99m seastamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;66:55E-62E.
3. Sridhara BS, Braat S, Rigo P, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015-1019.
4. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
5. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
6. Kiat H, Maddahi J, Roy LT, et al. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
7. Sridhara BS, Braat SH, Rigo P, et al. Myocardial perfusion imaging with technetium-99m-tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015-1019.
8. Maublant JC, Gachon P, Moins N. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med 1988;29:48-54.
9. Braat SH, Lahiri A, Itti R, Rigo P. Comparison of defect size 5 and 240 minutes after injection of tetrofosmin at peak exercise [Abstract]. J Nucl Med 1992;33:874.
10. Borges-Neto S, Coleman RE, Jones RH. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers. J Nucl Med 1990;31:1128-1132.
11. Heo J, Kegel J, Iskandrian AS, et al. Comparison of same-day protocols using technetium-99m-sestamibi myocardial imaging. J Nucl Med 1992;33: 186-191.
12. Jain D, Wackers FJ, Mattera J, et al. Biokinetic of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-1259.
13. King MA, Doherty PW, Schwinger RB, et al. Fast count-dependent digital filtering of nuclear medicine images: concise communication. J Nucl Med 1983;24:1039-1045.
14. Links JM, Jeremy RW, Dyer SM, et al. Wiener filtering improves quantification of regional myocardial perfusion with thallium-201 SPECT. J Nucl Med 1990;31:1230-1236.
15. Blokland KA, Reiber HH, Pauwels EK. Quantitative analysis in single photon emission tomography (SPET). Eur J Nucl Med 1992;19:47-61.
16. Braat SH, Leclercq B, Itti R, et al. Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols. J Nucl Med 1994;25:1581-1585.
17. Yong TK, Chambers J, Maisey MN, et al. Technetium-99m tetrofosmin myocardial perfusion scan: comparison of 1-day and 2-day protocols. Eur J Nucl Med 1996;23:320-325.
18. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution,dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-38.
19. Penny BC, King MA, Schwinger R, et al. Constrained least-squares restoration of nuclear medicine images: selecting the coarseness function. Med Phys 1987;14:849-858.
20. Ohnishi H, Takahashi M, Matsuo S, et al. Evaluation of SPECT image using a textural analysis. Jpn J Radiol Technol 1995;51:710-716.
21. Kotzki PO, Mariano-Goulart D, Quiquere M, et al. Optimum tomographic reconstruction parameters for HMPAO brain SPET imaging: a practical approach based on subjective and objective indexes. Eur J Nucl Med 1995; 22:671-677.
22. Madsen MT, Chang W, Hichwa RD. Spatial resolution and count density requirements in brain SPECT imaging. Phys Med Biol 1992;37:1625-1636.
23. Garcia EV, Cooke CD, Van Train KF, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990;66:23E-31E.